Home > Result Summaries: Compounds > abacavir/lamivudine/zidovudine > Result Summary for COL30470

Result Summary for COL30470

Result Summary

Protocol ID:	COL30470
Clinical Study ID:	QUAD001 (COL30470)
Official Title:	A Pilot, Randomised, Open-Label, Monocenter Study to Evaluate the Safety and Efficacy of a Quadruple Combination Therapy of Triple Combination Tablet (Trizivir) [abacavir, lamivudine, zidovudine] Plus Saquinavir-SGC/Ritonavir Versus Triple Combination Therapy of Combivir Plus Saquinavir-SGC/Rito ...
Phase:	Phase 4
Study Indications or Diseases:	Infection, Human immunodeficiency Virus
Generic Name:	abacavir/lamivudine/zidovudine
Trade/Product Name:	Ziagen,ZIAGENAVIR
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Staszewski et al: “The QUAD Study: A Pilot-Study to Assess the Efficacy and Safety of Trizivir + RTV-Boosted Saquinavir (TZV/SQVr) Compared to Combivir + RTV-Boosted Saquinavir (CBV/SQVr) in ART-Naive Patients with High viral load (VL) and Low CD4 Count. 24 Week Interim analysis. 9th European AIDS Conference, Warsaw, 25.-29.10.2003, abstract #F1/1